Last reviewed · How we verify

NCT06241651: CSP-UPGRADE

CSP Versus BiVP for Heart Failure Patients with RVP Upgraded to Cardiac Resynchronization Therapy

Recruiting now NA Last updated 12 March 2025
What this trial tests

NA trial testing Conduction system pacing in Conduction System Pacing in 66 participants. Currently enrolling.

Timeline
1 January 2024
Primary endpoint
1 March 2026
1 March 2026

Quick facts

Lead sponsorThe First Affiliated Hospital with Nanjing Medical University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment66
Start date1 January 2024
Primary completion1 March 2026
Estimated completion1 March 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Who can join

Adults 18 to 80, any sex, with Conduction System Pacing or Biventricular Pacing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study is a prospective, multicenter, non-inferiority, randomized controlled trail. It aims to investigate whether the efficacy of conduction system pacing (CSP) is non-inferior to biventricular pacing (BiVP) in patients with heart failure and right ventricular pacing (RVP) requiring upgrading to cardiac resynchronization therapy (CRT).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Is Conduction System Pacing a Valuable Alternative to Biventricular Pacing for Cardiac Resynchronization Therapy?
    Castagno D, Zanon F, Pastore G, De Ferrari GM, et al · · 2024 · cited 2× · PMID 38786966 · DOI 10.3390/jcdd11050144

Verify or expand the search:

Other trials of Conduction system pacing

Trials testing the same drug.

Other recruiting trials for Conduction System Pacing

Currently open trials in the same condition.

Other The First Affiliated Hospital with Nanjing Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06241651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing